Nisa Investment Advisors
RYTM icon

Nisa Investment Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

Nisa Investment Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
1,494
+356
+31% +$32.2K ﹤0.01% 1321
2026
Q1 		$99K Sell
1,138
-12,001
-91% -$1.17M ﹤0.01% 1427
2025
Q4 		$1.41M Sell
13,139
-115
-0.9% -$12.2K ﹤0.01% 727
2025
Q3 		$1.34M Buy
13,254
+12,000
+957% +$1.11M 0.01% 755
2025
Q2 		$79.2K Buy
1,254
+14
+1% +$857 ﹤0.01% 1468
2025
Q1 		$65.7K Sell
1,240
-45
-4% -$2.5K ﹤0.01% 1509
2024
Q4 		$71.9K Sell
1,285
-64,955
-98% -$3.59M ﹤0.01% 1569
2024
Q3 		$3.47M Sell
66,240
-308,107
-82% -$14.8M 0.02% 515
2024
Q2 		$15.4M Buy
374,347
+229,056
+158% +$9.14M 0.1% 205
2024
Q1 		$6.3M Buy
145,291
+144,035
+11,468% +$6.3M 0.04% 379
2023
Q4 		$57.7K Buy
1,256
+600
+91% +$18.9K ﹤0.01% 1607
2023
Q3 		$15K Buy
656
+620
+1,722% +$13.9K ﹤0.01% 2089
2023
Q2 		$594 Buy
+36
New +$650 ﹤0.01% 2530
2022
Q2 		– Sell
-23,400
Closed -$270K – 2494
2022
Q1 		$270K Buy
23,400
+19,800
+550% +$174K ﹤0.01% 1264
2021
Q4 		$27K Buy
3,600
+3,050
+555% +$34.3K ﹤0.01% 1870
2021
Q3 		$7K Hold
550
– – ﹤0.01% 2242
2021
Q2 		$11K Hold
550
– – ﹤0.01% 2216
2021
Q1 		$12K Hold
550
– – ﹤0.01% 2190
2020
Q4 		$16K Sell
550
-1,350
-71% -$34.3K ﹤0.01% 2155
2020
Q3 		$41K Buy
+1,900
New +$43.6K ﹤0.01% 1876

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nisa Investment Advisors's RYTM Position: Q2 2026 in Review

Nisa Investment Advisors increased its Rhythm Pharmaceuticals (RYTM) stake by 31% in Q2 2026, buying an estimated $32.2K and bringing the position to 1,494 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Nisa Investment Advisors first reported a position in RYTM in Q3 2020 and has held it in 20 quarters since. The position peaked at $15.4M in Q2 2024. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Nisa Investment Advisors held 1,494 shares of Rhythm Pharmaceuticals worth $166K as of Q2 2026.
  • Nisa Investment Advisors bought 356 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $32.2K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1321 holding.
  • Nisa Investment Advisors first reported a position in Rhythm Pharmaceuticals in Q3 2020 and has held it in 20 quarters since.
  • Nisa Investment Advisors's Rhythm Pharmaceuticals position peaked at $15.4M in Q2 2024.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.